1. Toschi V, Motta A, Castelli C, et al. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke1998;29:1759-1759.
2.
2. Bick RL. Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects. Hematol Oncol Clin North Am2000;14:1117-1117.
4. Klein BA, Olwin JH. A survey of the pathogenesis of retinal venous occlusion: Emphasis upon choice of th4erapy and an analysis of the therapeutic results in fifty-three patients. Arch Ophthalmol56:207-207,195-195.
5.
5. Green BA, Chan CC, Hutchins GM. Central retinal vein occlusion: A prospective histopathologic study of twenty-nine eyes in 28 cases. Retina1981;1:27-27.
6.
6. The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol1996;114:545-545.
7.
7. Schwab PJ, Okun E, Fahey FJ. Reversal of retinopathy in Waldenstroms macroglobulinemia by plasmapheresis: A report of two cases. Arch Ophthalmol1960;64:67-67.
8.
8. Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol1996;37:200-200.
9.
9. Khamashta MA, Cuadrado MJ, Mujic F. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med1995;332:993-993.